Search Results - "Garin, A.M."

790P Palliative chemotherapy in patients with advanced nonseminomatous germ cell tumors (aNSGCT) by Tryakin, A., Fedyanin, M., Bulanov, A., Rumyantsev, A., Sergeev, Y., Petrova, G., Matveev, V., Volkova, M., Klimov, A., Fainstein, I., Akhmedov, B., Kurmukov, I., Garin, A.M., Tjulandin, S.

Get full text

3505 ORAL Glufosfamide (GLU) in metastatic pancreatic adenocarcinoma previously treated with gemcitabine: Results of a Phase III trial by Langmuir, V.K, Ciuleanu, T.E, Pavlovsky, A.V, Bodoky, G, Garin, A.M, Kroll, S, Colowick, A.B, Tidmarsh, G.T

Get full text

982P - Two-weekly accelerated BEP (aBEP) regimen as induction chemotherapy (CT) in intermediate and poor prognosis patients (pts) with nonseminomatous germ cell tumours (NSGCT): Final results of phase II trial by Tryakin, Fedyanin, M., Segeev, Y., Bulanov, A., Matveev, V.B., Volkova, M., Klimov, A., Fainstein, I., Akhmedov, B., Menshikova, S., Zakharova, T., Garin, A.M., Chekini, D., Chekini, A., Sekhina, O., Tjulandin, S.

“…Three-weekly BEP has been a standard of CT of advanced NSGCT for last two decades. We performed a phase II study to assess the efficacy and toxicity of…”
Get full text

Two-weekly accelerated BEP (aBEP) regimen as induction chemotherapy (CT) in intermediate and poor prognosis patients (pts) with nonseminomatous germ cell tumours (NSGCT): Final results of phase II trial by Tryakin, Fedyanin, M., Segeev, Y., Bulanov, A., Matveev, V.B., Volkova, M., Klimov, A., Fainstein, I., Akhmedov, B., Menshikova, S., Zakharova, T., Garin, A.M., Chekini, D., Chekini, A., Sekhina, O., Tjulandin, S.

Get full text

A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy by Kanagavel, D., Pokataev, I.A., Fedyanin, M.Y., Tryakin, A.A., Bazin, I.S., Narimanov, M.N., Yakovleva, E.S., Garin, A.M., Tjulandin, S.A.

“…This retrospective study was carried out to evaluate the prognostic significance of clinical factors in patients treated for metastatic gastric cancer with…”
Get full text

920 Secondary leukemia caused by etoposide containing chemotherapy in germ cell cancer patients by Tjulandin, S.A., Garin, A.M.

“…Several reports have suggested that etoposide containing therapy caused a secondary leukemia in germ cell cancer pts. From December 87 to December 1993 187 pts…”
Get full text

914 The role of a cytoreductive surgery in nonseminomatous germ cell tumor patients with small retroperitoneal mass after induction chemotherapy by Karpov, S.A., Tjulandin, S.A., Molchanov, G.V., Garin, A.M.

“…We identify 64 nonseminomatous germ cell tumor pts, received 4 cycles ofthe induction chemotherapy with VAB-6, BEP or EP, who presented a residual…”
Get full text

Long term results of treatment in patients with extragonadal germ cell tumours by Gutierrez Delgado, F, Tjulandin, S A, Garin, A M

“…From 1979 to 1991 56 patients with extragonadal germ cell tumours (EGCT) received cisplatin based chemotherapy. From 16 patients with seminomatous EGCT 13…”
Get more information

Paclitaxel and cisplatin as salvage treatment in patients with non-seminomatous germ cell tumour who failed to achieve a complete remission on induction chemotherapy by Tjulandin, S.A., Titov, D.A., Breder, V.V., Sidorova, N.J., Popov, A.J., Kupchan, D.Z., Garin, A.M.

“…The purpose of this study was to evaluate the efficacy and toxicity of paclitaxel and cisplatin combination chemotherapy as salvage treatment in patients with…”
Get full text

VAB-6 and cisplatin-cyclophosphamide combinations in the treatment of metastatic seminoma patients: the U.S.S.R. experience by Tjulandin, S A, Khlebnov, A V, Nasirova, R J, Mikhina, Z P, Molchanov, G V, Sholokhov, V N, Sokolov, V A, Vetrova, N A, Garin, A M

“…In a non-randomized study the treatment results of 59 patients with disseminated seminoma were evaluated: 21 patients were treated with a VAB-6 combination and…”
Get more information